Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 18.71 USD 1.19% Market Closed
Market Cap: 608.8m USD
Have any thoughts about
Capricor Therapeutics Inc?
Write Note

Capricor Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Capricor Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Capricor Therapeutics Inc
NASDAQ:CAPR
Free Cash Flow
-$36m
CAGR 3-Years
-33%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$17.8B
CAGR 3-Years
-3%
CAGR 5-Years
7%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$5.5B
CAGR 3-Years
-15%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-15%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.2B
CAGR 3-Years
23%
CAGR 5-Years
11%
CAGR 10-Years
20%

See Also

What is Capricor Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-36m USD

Based on the financial report for Jun 30, 2024, Capricor Therapeutics Inc's Free Cash Flow amounts to -36m USD.

What is Capricor Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-29%

Over the last year, the Free Cash Flow growth was -73%. The average annual Free Cash Flow growth rates for Capricor Therapeutics Inc have been -33% over the past three years , -29% over the past five years .

Back to Top